Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Hippieslayer who wrote (28702)	4/15/1999 7:29:00 AM
From: Henry Niman	Read Replies (2) \| Respond to of 32384

Your link was for human's receiving Herceptin for breast cancer. LGND has not release their human breast cancer data. Their breast cancer data is on rats. I didn't understand the relevance of your link. Do you know of a PR firm that can convince ABC News that the rat data presented at AACR, deserves the same press as the human data, also presented at AACR? Maybe you can explain what you meant. News comes out of meetings such as AACR, which is where the ABC story originated. They have a tendency to focus on human results at a Cancer Meeting such as AACR where hundreds or thousands of abstracts are presented on various cancer treatments or approaches. Reuter's carried a rather impressive story on Targretin treatment of rats which generated MD enthusiasm: dailynews.yahoo.com This story came out of AACR. Why do you think that a PR firm could change ABC's approach?